Approval · Notice of Compliance 5274 · 1995
INNOHEP: Notice of Compliance 5274
Issued May 24, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5274
- Date
- May 24, 1995
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anticoagulant / antithrombotic agent
Products in this notice
Medicinal ingredients
- TINZAPARIN SODIUM 11,700 UNIT per ML
- TINZAPARIN SODIUM 10,000 UNIT per ML